Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Topics

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Top stories - CBS News - November 4
Weight loss drug industry injects wealth into Novo Nordisk home country
Top stories - CBS News - November 3
Novo Nordisk's Wegovy Sales Beat Expectations
Business - The Wall Street Journal - November 6
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Business - CNBC - November 6
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs
Top stories - CBS News - November 9
Novo Nordisk's obesity-fighting drugs fatten Denmark's economy
Top stories - CBS News - November 3
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Business - CNBC - October 23
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Business - CNBC - October 30

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

Topics

Related

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Weight loss drug industry injects wealth into Novo Nordisk home country

Novo Nordisk's Wegovy Sales Beat Expectations

Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

Novo Nordisk's obesity-fighting drugs fatten Denmark's economy

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

More from The Wall Street Journal

Energy & Utilities Roundup: Market Talk

Financial Services Roundup: Market Talk

Auto & Transport Roundup: Market Talk

Volkswagen Chooses Rivian's Kjell Gruner to Lead U.S. Business

New AI Entertainment Studio Gets Backing From Peter Chernin, Andreessen Horowitz